| This week's sponsor is RAPS. | |  | |
Today's Rundown Featured Story | | | Monday, November 6, 2017 Cancer vaccine startup NousCom has raised €42 million ($49 million). The round equips a team last seen leading Okairos to a €250 million buyout by GlaxoSmithKline to take off-the-shelf neoantigen cancer vaccine NOUS-209 into the clinic. |
|
|
Top Stories Monday, November 6, 2017 Agios and Shire veteran Ann Barbier, M.D., Ph.D., has become the new chief medical officer at RNA biotech Translate Bio. Barbier will be responsible for leading all clinical research and development, medical affairs and related functions at the Cambridge, Massachusetts-based biotech. Monday, November 6, 2017 After a good run that has seen his company pass key tests, set up deals with Big Pharmas and have its market cap top $1.5 billion, Aimmune chief Stephen Dilly, M.B.B.S., Ph.D., is calling it a day. Monday, November 6, 2017 Did you know pediatric plans are a requirement for virtually all new medicines, not just those identified as available for children? Gain insights from Dr. Dehlinger-Kremer, chair of the EFGCP and EUCROF on this requirement. Monday, November 6, 2017 Exicure has pulled in more money to advance its pipeline of oligonucleotides. The latest raise sees Exicure branch out beyond the tech investors that bankrolled its atypical rise to secure cash for its move deeper into the clinic. Monday, November 6, 2017 Just a few months after telling TherapeuticsMD that its treatment for vaginal pain during sexual intercourse lacked data on safety, the FDA has changed its mind. Monday, November 6, 2017 The biopharma services company Bioclinica already supports clinical research and offers medical imaging and eHealth, but it is now looking to broaden its reach with the purchase of MDDX Research & Informatics. Monday, November 6, 2017 The brain cancer glioblastoma is notoriously difficult to treat, largely because the blood-brain barrier prevents many drugs from breaking through and reaching their target. Researchers in the U.K. tested AstraZeneca’s PARP inhibitor Lynparza and found it can penetrate the blood-brain barrier and invade glioblastoma tumors. Monday, November 6, 2017 Medtronic’s Intellis platform grabbed a CE mark for peripheral nerve and spinal cord stimulation. | This week's sponsor is PRA Health Sciences. | |  | Developing or reformulating a CNS Therapeutic?
The Fundamentals of Human Abuse Potential (HAP) Studies: A 7-Point Checklist
Download and Learn More |
Resources Sponsored by: Veeva Systems Gain a complete, real-time view of quality and streamline operations. Incorporate partners into processes for critical oversight and 30% greater efficiency, and transform cross-functional processes like change control. Sponsored by: Reprints Desk SO CLOSE AND YET SO FAR. Is that how many documents seem to you? Getting what you want—when, where, and how you want it—can be a real pain. That’s why we created this concise guide to getting around the obstacles that stand between you and the information your organization needs. Download the whitepaper to learn more. Presented by: DSM Biomedical Discover DSM's Dyneema Purity® membrane, an effective and efficient material to construct stent grafts used in minimally invasive surgeries to treat both cardiovascular and peripheral arterial diseases. Sponsored by: ePharmaSolutions As clinical trials become more complex, safety document distribution to investigative sites has reached the point that demands a solution. Sponsored by: Ashfield Healthcare Join this webinar to discover tested and proven solutions to manage vacancies. Presented by Tyler Cowan, VP, Client Solutions, Ashfield US, you’ll learn how to maintain and build momentum in field sales despite turnover. Sponsored by: Veeva CROs are leading an industry wide shift to modernize clinical systems and clinical trial processes. Presented By: Charles River Join us as we discuss how Charles River Celsis® helped Labor L+S AG validate a 7-day membrane filtration sterility test using existing protocols. Presented By: Catalent Learn how Catalent Biologics is paving the way for flexible biologics development and manufacturing through advanced technologies and fully integrated multi-product facility. Presented By: Catalent Download the eBook to get articles from various Elsevier journals highlighting developments in ADC technology. Presented By: Catalent Learn how cell development and process scale-up can be optimized for antibodies requiring additional processing. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. | 
